Sensyne Health (SENS)

Sector:

Health Care

Index:

FTSE AIM All-Share

 32.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 160.00
  • 52 Week Low: 29.50
  • Currency: UK Pounds
  • Shares Issued: 128.57m
  • Volume: 259,240
  • Market Cap: £41.79m
  • RiskGrade: 275

Sensyne chairman stands down following Downing Street appointment

By Iain Gilbert

Date: Wednesday 24 Oct 2018

LONDON (ShareCast) - (Sharecast News) - Newly listed clinical AI tech company Sensyne Health's chairman John Bell stepped down as chairman of the board on Wednesday.
Sensyne told investors that Bell had opted to walk away from the AIM-quoted outfit in order to avoid any potential conflicts of interest that could arise as a result of his work with Downing Street on the government's life sciences industrial strategy.

Bell, who authored the government's life sciences strategy document, has been instrumental in delivering a programme defined in the report to grow the life sciences sector in the UK.

Sensyne will replace Bell with Charles Swingland on an interim basis. Swingland will return to his post as a non-executive director when Sensyne's search for a permanent chairman is complete.

Bell said: "I have thoroughly enjoyed my time at Sensyne, supporting the business through its initial development and recent successes. Now is the right time to relinquish my Board responsibilities to avoid any potential conflicts of interest."

As of 0835 BST, Sensyne shares had slipped 2.05% to 191p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Sensyne Health Market Data

Currency UK Pounds
Share Price 32.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 160.00
52 Week Low 29.50
Volume 259,240
Shares Issued 128.57m
Market Cap £41.79m
RiskGrade 275

Sensyne Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
34.89% above the market average34.89% above the market average34.89% above the market average34.89% above the market average34.89% above the market average
63.16% above the sector average63.16% above the sector average63.16% above the sector average63.16% above the sector average63.16% above the sector average
Price Trend
50.78% below the market average50.78% below the market average50.78% below the market average50.78% below the market average50.78% below the market average
69.23% below the sector average69.23% below the sector average69.23% below the sector average69.23% below the sector average69.23% below the sector average
Income Not Available
Growth
15.82% above the market average15.82% above the market average15.82% above the market average15.82% above the market average15.82% above the market average
37.14% above the sector average37.14% above the sector average37.14% above the sector average37.14% above the sector average37.14% above the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Sensyne Health Dividends

No dividends found

Trades for 04-Aug-2020

Time Volume / Share Price
17:08 25,000 @ 32.50p
12:23 1,851 @ 32.05p
11:46 10,000 @ 32.00p
10:28 100,000 @ 32.25p
11:00 25,000 @ 31.00p

Sensyne Health Key Personnel

CEO Paul Drayson

Top of Page